Evaluation of the Effect of Biofiller PRP Application on Knee Osteoarthritis
Launched by NECMETTIN ERBAKAN UNIVERSITY · Apr 18, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the effects of a treatment called biofiller PRP on people with knee osteoarthritis, a condition that causes pain and stiffness in the knee. The researchers want to see if this treatment can help reduce pain, improve movement, enhance quality of life, and increase the thickness of the cartilage in the knee, which is important for joint health.
To participate in this study, individuals need to be between 45 and 65 years old and have been diagnosed with knee osteoarthritis for at least six months. They should also be experiencing moderate pain. However, people with certain conditions, like a history of knee surgery, inflammatory arthritis, or other serious health issues, will not be eligible. The trial is not currently recruiting participants, but if you qualify, you can expect to receive the biofiller PRP treatment and be monitored for improvements over time. This study aims to provide valuable information on how this treatment might help those suffering from knee osteoarthritis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1-45-65 years old 2-Diagnosis of knee OA according to ACR clinical and radiological diagnostic criteria 3-Kellgren Lawrence stage II or III 4-Knee pain for at least 6 months 5-Visual analog scale (VAS) score of at least 3 or more
- Exclusion Criteria:
- • 1 - History of surgery or traumatic injury 2-Inflammatory arthritis 3-History of cancer, bleeding diathesis and psychiatric disease 4-Those who have a disease that limits their participation in exercises (severe chronic obstructive lung disease, severe heart failure, history of cerebrovascular events) 5-Hip and ankle problems 6-Participating in another physical therapy program in the last 3 months 7-History of intra-articular injections in the last 6 months
About Necmettin Erbakan University
Necmettin Erbakan University is a prominent academic institution dedicated to advancing health sciences and research through innovative clinical trials. With a commitment to excellence in education and research, the university leverages its multidisciplinary approach to foster collaborations that enhance patient care and medical advancements. By conducting rigorous clinical studies, Necmettin Erbakan University seeks to contribute valuable insights to the medical community, ultimately improving treatment outcomes and fostering evidence-based practices in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
BANU ORDAHAN
Principal Investigator
Necmettin Erbakan University, Konya, Turkey
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported